CoChat

Parents’ Perceptions of the Usefulness of Chromosomal Microarray Analysis for Children with Autism Spectrum Disorders

Open access
Reiff, Marian, Giarelli, Ellen, Bernhardt, Barbara A., Easley, Ebony, Spinner, Nancy B., Sankar, Pamela L., Mulchandani, Surabhi · 2015 · Journal of Autism and Developmental Disorders
Cited by 81

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Clinical guidelines recommend chromosomal microarray analysis (CMA) for all children with autism spectrum disorders (ASDs). We explored the test’s perceived usefulness among parents of children with ASD who had undergone CMA, and received a result categorized as pathogenic, variant of uncertain significance, or negative. Fifty-seven parents participated in a semi-structured telephone interview, and 50 also completed a survey. Most parents reported that CMA was helpful for their child and family. Major themes regarding perceived usefulness were: medical care, educational and behavioral interventions, causal explanation, information for family members, and advancing knowledge. Limits to utility, uncertainties and negative outcomes were also identified. Our findings highlight the importance of considering both health and non-health related utility in genomic testing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10803-015-2489-3

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 57

  1. Ali-Khan, S. E., Daar, A. S., Shuman, C., Ray, P. N., & Scherer, S. W. (2009). Whole genome scanning: Resolving clinical diagnosis and management amidst complex data. Pediatric Research, 66(4), 357–363. · DOI
  2. Battaglia, A., Doccini, V., Bernardini, L., Novelli, A., Loddo, S., Capalbo, A., & Carey, J. C. (2013). Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. European Journal of Paediatric Neurology, 17(6), 589–599. · DOI · Paper page
  3. Bazeley, P. (2007). Qualitative analysis with Nvivo. Thousand Oaks, CA: Sage Publications Ltd.
  4. Beaudet, A. L. (2013). The utility of chromosomal microarray analysis in developmental and behavioral pediatrics. Child Development, 84(1), 121–132. · DOI
  5. Bernard, H. R. (2013). Social research methods: Qualitative and quantitative approaches. Thousand Oaks, CA: Sage Publications.
  6. Biesecker, B. B., & Erby, L. (2008). Adaptation to living with a genetic condition or risk: A mini-review. Clinical Genetics, 74(5), 401–407. doi: 10.1111/j.1399-0004.2008.01088.x . · DOI
  7. Bradbury, A. R., Patrick-Miller, L., & Domchek, S. (2014). Multiplex genetic testing: Reconsidering utility and informed consent in the era of next-generation sequencing. Genetics in Medicine, 17, 97–98. · DOI
  8. Burke, W., Laberge, A. M., & Press, N. (2010). Debating clinical utility. Public Health Genomics, 13(4), 215–223. doi: 10.1159/000279623 . · DOI
  9. Carter, M., & Scherer, S. (2013). Autism spectrum disorder in the genetics clinic: A review. Clinical Genetics, 83(5), 399–407. · DOI · Paper page
  10. Chao, S., Roberts, J. S., Marteau, T. M., Silliman, R., Cupples, L. A., & Green, R. C. (2008). Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL study. Alzheimer Disease and Associated Disorders, 22(1), 94–97. doi: 10.1097/WAD.0b013e31815a9dcc . · DOI · Paper page
  11. Chen, L., Xu, L., Huang, T., & Dhar, S. U. (2013). Autism genetic testing: A qualitative study of awareness, attitudes, and experiences among parents of children with autism spectrum disorders. Genetics in Medicine, 15(4), 274–281. · DOI
  12. Condit, C. (2010). Public understandings of genetics and health. Clinical Genetics, 77(1), 1–9. · DOI
  13. Cooper, G. M., Coe, B. P., Girirajan, S., Rosenfeld, J. A., Vu, T. H., Baker, C., et al. (2011). A copy number variation morbidity map of developmental delay. Nature Genetics, 43, 838–846. · DOI · Paper page
  14. Coulter, M. E., Miller, D. T., Harris, D. J., Hawley, P., Picker, J., Roberts, A. E., & Irons, M. (2011). Chromosomal microarray testing influences medical management. Genetics in Medicine, 13(9), 770–776. · DOI
  15. Cuccaro, M. L., Czape, K., Alessandri, M., Lee, J., Deppen, A. R., Bendik, E., & Hahn, S. (2014). Genetic testing and corresponding services among individuals with autism spectrum disorder (ASD). American Journal of Medical Genetics Part A, 164(10), 2592–2600. · DOI
  16. Darilek, S., Ward, P., Pursley, A., Plunkett, K., Furman, P., Magoulas, P., & Eng, C. M. (2008). Pre-and postnatal genetic testing by array-comparative genomic hybridization: Genetic counseling perspectives. Genetics in Medicine, 10(1), 13–18. · DOI
  17. Dar-Nimrod, I., & Heine, S. J. (2011). Genetic essentialism: On the deceptive determinism of DNA. Psychological Bulletin, 137(5), 800. · DOI · Paper page
  18. Ellison, J. W., Ravnan, J. B., Rosenfeld, J. A., Morton, S. A., Neill, N. J., Williams, M. S., & Traylor, R. N. (2012). Clinical utility of chromosomal microarray analysis. Pediatrics, 130(5), e1085–e1095. · DOI · Paper page
  19. Eriksson, M. A., Westerlund, J., Hedvall, Å., Åmark, P., Gillberg, C., & Fernell, E. (2013). Medical conditions affect the outcome of early intervention in preschool children with autism spectrum disorders. European Child and Adolescent Psychiatry, 22(1), 23–33. · DOI
  20. Fanos, J. H. (2012). New “first families”: The psychosocial impact of new genetic technologies. Genetics in Medicine, 14(2), 189–190. · doi:10.1038/gim.2011.17
  21. Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2009). Evaluating the utility of personal genomic information. Genetics in Medicine, 11(8), 570–574. · DOI · Paper page
  22. Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., & Ormond, K. E. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15, 565–574. · DOI · Paper page
  23. Grosse, S. D., & Khoury, M. J. (2006). What is the clinical utility of genetic testing? Genetics in Medicine, 8(7), 448–450. · DOI · Paper page
  24. Haga, S. B., Barry, W. T., Mills, R., Ginsburg, G. S., Svetkey, L., Sullivan, J., & Willard, H. F. (2013). Public knowledge of and attitudes toward genetics and genetic testing. Genetic Testing and Molecular Biomarkers, 17(4), 327–335. · DOI · Paper page
  25. Hayeems, R. Z., Hoang, N., Chenier, S., Stavropoulos, D. J., Pu, S., Weksberg, R., & Shuman, C. (2014). Capturing the clinical utility of genomic testing: Medical recommendations following pediatric microarray. European Journal of Human Genetics. doi: 10.1038/ejhg.2014.260 . · DOI
  26. Hayward, D., Eikeseth, S., Gale, C., & Morgan, S. (2009). Assessing progress during treatment for young children with autism receiving intensive behavioural interventions. Autism : The International Journal of Research and Practice, 13(6), 613–633. doi: 10.1177/1362361309340029 . · DOI · Paper page
  27. Heil, K. M., & Schaaf, C. P. (2013). The genetics of autism spectrum disorders—A guide for clinicians. Current Psychiatry Reports, 15(1), 1–8.
  28. Kegley, J. (2003). An ethical imperative: Genetics education for physicians and patients. Medicine and Law, 22(2), 275–283.
  29. Khoury, M. J., McBride, C. M., Schully, S. D., Ioannidis, J. P., Feero, W. G., Janssens, A. C. J., & Cargill, M. (2010). The scientific foundation for personal genomics: Recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genetics in Medicine, 11(8), 559–567. · DOI · Paper page
  30. Lebowitz, M. S., Rosenthal, J. E., & Ahn, W. K. (2013). Effects of biological versus psychosocial explanations on stigmatization of children with ADHD. Journal of Attention Disorders. doi: 10.1177/1087054712469255 . · DOI
  31. Lenhard, W., Breitenbach, E., Ebert, H., Schindelhauer-Deutscher, H. J., & Henn, W. (2005). Psychological benefit of diagnostic certainty for mothers of children with disabilities: Lessons from down syndrome. American Journal of Medical Genetics, 133A(2), 170–175. doi: 10.1002/ajmg.a.30571 . · DOI
  32. Lipinski, S. E., Lipinski, M. J., Biesecker, L. G., & Biesecker, B. B. (2006). Uncertainty and perceived personal control among parents of children with rare chromosome conditions: The role of genetic counseling. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 142(4), 232–240. doi: 10.1002/ajmg.c.30107 . · DOI · Paper page
  33. Makela, N. L., Birch, P. H., Friedman, J. M., & Marra, C. A. (2009). Parental perceived value of a diagnosis for intellectual disability (ID): A qualitative comparison of families with and without a diagnosis for their child’s ID. American Journal of Medical Genetics. Part A, 149A(11), 2393–2402. doi: 10.1002/ajmg.a.33050 . · DOI
  34. Manning, M., & Hudgins, L. (2010). Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genetics in Medicine, 12(11), 742–745. doi: 10.1097/GIM.0b013e3181f8baad . · DOI · Paper page
  35. McMahon, W. M., Baty, B. J., & Botkin, J. R. (2006). Genetic counseling and ethical issues for autism. American Journal of Medical Genetics - Seminars in Medical Genetics, 142(1), 52–57. doi: 10.1002/ajmg.c.30082 . · DOI · Paper page
  36. Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook (2nd ed.). Thousand Oaks, CA: Sage.
  37. Miller, F. A., Hayeems, R. Z., & Bytautas, J. P. (2010b). What is a meaningful result? Disclosing the results of genomic research in autism to research participants. European Journal of Human Genetics, 18(8), 867–871. · DOI
  38. Narcisa, V., Discenza, M., Vaccari, E., Rosen-Sheidley, B., Hardan, A. Y., & Couchon, E. (2012). Parental interest in a genetic risk assessment test for autism spectrum disorders. Clinical Pediatrics, 52(2), 139–146. · DOI
  39. Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., & Hurles, M. E. (2006). Global variation in copy number in the human genome. Nature, 444(7118), 444–454. doi: 10.1038/nature05329 . · DOI · Paper page
  40. Regier, D., Friedman, J., Makela, N. L., Ryan, M., & Marra, C. (2009). Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: Willingness to pay from families of affected children. Clinical Genetics, 75(6), 514–521. · DOI
  41. Reiff, M., Bernhardt, B. A., Mulchandani, S., Soucier, D., Cornell, D., Pyeritz, R. E., & Spinner, N. B. (2012). “What does it mean?”: Uncertainties in understanding results of chromosomal microarray testing. Genetics in Medicine, 14(2), 250–258. · DOI
  42. Reiff, M., & Mulchandani, S. (2015). Integrating genetics into healthcare: Implications of genomic testing for individuals with autism spectrum disorders. In E. Giarelli, & K. Fisher (Eds.), Integrated healthcare for people with autism spectrum disorders: Interdisciplinary planning and delivery of care. Springfield, IL: Charles C. Thomas, Publishers, Ltd.
  43. Reiff, M., Ross, K., Mulchandani, S., Propert, K. J., Pyeritz, R. E., Spinner, N. B., & Bernhardt, B. A. (2013). Physicians’ perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clinical Genetics, 83(1), 23–30. · DOI
  44. Riggs, E. R., Wain, K. E., Riethmaier, D., Smith-Packard, B., Faucett, W., Hoppman, N., & Miller, D. T. (2014). Chromosomal microarray impacts clinical management. Clinical Genetics, 85(2), 147–153. · DOI · Paper page
  45. Roberts, J. L., Hovanes, K., Dasouki, M., Manzardo, A. M., & Butler, M. G. (2014). Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services. Gene, 535(1), 70–78. · DOI · Paper page
  46. Rosas-Blum, E., Shirsat, P., & Leiner, M. (2007). Communicating genetic information: A difficult challenge for future pediatricians. BMC Medical Education, 7(1), 17. · doi:10.1186/1472-6920-7-17
  47. Rossi, J., Newschaffer, C., & Yudell, M. (2013). Autism spectrum disorders, risk communication, and the problem of inadvertent harm. Kennedy Institute of Ethics Journal, 23(2), 105–138. · DOI
  48. Sasson, N. J., Lam, K., Parlier, M., Daniels, J. L., & Piven, J. (2013). Autism and the broad autism phenotype: Familial patterns and intergenerational transmission. Journal of Neurodevelopmental Disorders, 5(1), 11. · DOI · Paper page
  49. Scherer, S. W., & Dawson, G. (2011). Risk factors for autism: Translating genomic discoveries into diagnostics. Human Genetics, 130(1), 123–148. · DOI
  50. Shen, Y., Dies, K. A., Holm, I. A., Bridgemohan, C., Sobeih, M. M., Caronna, E. B., & Miller, D. T. (2010). Clinical genetic testing for patients with autism spectrum disorders. Pediatrics, 125(4), e727–e735. doi: 10.1542/peds.2009-1684 . · DOI · Paper page
  51. Shen, J., Lincoln, S., & Miller, D. T. (2014). Advances in Genetic Discovery and Implications for Counseling of Patients and Families with Autism Spectrum Disorders. Current Genetic Medicine Reports, 2(3), 124–134. · DOI
  52. Shen, J., & Miller, D. T. (2014). Advances in genetic diagnosis of autism spectrum disorders. Current Pediatrics Reports, 2(2), 71–81. · DOI
  53. Tabor, H. K., & Cho, M. K. (2007). Ethical implications of array comparative genomic hybridization in complex phenotypes: Points to consider in research. Genetics in Medicine, 9(9), 626–631. doi: 10.1097/GIM.0b013e3181485688 . · DOI
  54. Trottier, M., Roberts, W., Drmic, I., Scherer, S. W., Weksberg, R., Cytrynbaum, C., & Miller, F. A. (2013). Parents’ perspectives on participating in genetic research in autism. Journal of Autism and Developmental Disorders, 43(3), 556–568. · DOI
  55. Turbitt, E., Halliday, J., Amor, D., & Metcalfe, S. (2014). Preferences for results from genomic microarrays: Comparing parents and health care providers. Clinical Genetics, 87, 21–29. · DOI
  56. Veenstra-VanderWeele, J., Christian, S. L., & Cook, E. H. (2004). Autism as a paradigmatic complex genetic disorder. Annual Review of Genomics and Human Genetics, 5, 379–405. doi: 10.1146/annurev.genom.5.061903.180050 . · DOI · Paper page
  57. Yudell, M., Tabor, H. K., Dawson, G., Rossi, J., Newschaffer, C. J., & Working Group in Autism Risk Communication and Ethics. (2013). Priorities for autism spectrum disorder risk communication and ethics. Autism: The International Journal of Research and Practice, 17(6), 701–722. doi: 10.1177/1362361312453511 . · DOI

Cited by

See all 81

Metadata

Authors
Reiff, M., Giarelli, E., Bernhardt, B. A., Easley, E., Spinner, N. B., Sankar, P. L., & Mulchandani, S.
Venue
Journal of Autism and Developmental Disorders
Published
2015-06-12
Volume
45
Issue
10
Pages
3262-3275
ISSN
  • 0162-3257 (ISSN-L)
  • 1573-3432
OpenAlex
W1956051203
Cited by
81
References
11
FWCI
4.24
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)
Funders
National Human Genome Research Institute of the National Institutes of Health (R21-HG-006560)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Parents’ Perceptions of the Usefulness of Chromosomal Microarray Analysis for Children with Autism Spectrum Disorders. https://app.cochat.ai/papers/10.1007/s10803-015-2489-3
The paper
Reiff, M., Giarelli, E., Bernhardt, B. A., Easley, E., Spinner, N. B., Sankar, P. L., & Mulchandani, S. (2015). Parents’ Perceptions of the Usefulness of Chromosomal Microarray Analysis for Children with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-015-2489-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.